Tirzepatide Weight Loss Treatment
In recent years, type 2 diabetes has become common. Most scientists are making concerted efforts to develop a life-changing medication. Finally, one medicine, among many, Tirzepatide, has gained widespread attention. Mounjato, the new medicine, was given the green light by the US Food and Drug Administration in May 2022. It is the first medication that aims to treat both conditions. It’s a combination glucagon-like peptide-1 receptor agonist (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist used to treat individuals with type 2 diabetes.
The fact that this medication shares the advantages of GIP and GLP-1 receptor agonists sets it apart from all others. GIP promotes weight loss by lowering both food intake and energy expenditure. The combination of GLP-1 and GIP produces an effect on metabolic dysregulation.
What is Tirzepatide ?
Tirzepatide is an injectable drug used to treat diabetes and reduce blood sugar levels. It is administered once weekly. While many similar drugs are available, this one has the added benefit of treating two problems at once.
Those with type 2 diabetes are the target population, but off-label use for weight loss is possible. Tirzepatide works best when combined with other healthful lifestyle choices, such as a nutritious diet and regular physical activity.
Why are obesity doctors enthusiastic about Tirzepatide weight loss?
Tirzepatide is a medicine being researched for its potential to help persons with obesity and type 2 diabetes lose weight. It also helps to better manage their blood sugar levels.
It has shown encouraging results in preliminary investigations, which may thrill doctors who treat obese patients. Throughout a 26-week study, those who took Tirzepatide lost an average of 11% of their body weight, while those who took a placebo lost an average of 2.5%. Tirzepatide has also been proven to benefit glycaemic management, blood pressure, and cholesterol.
If given the green light by regulatory bodies, it might be a game-changer for persons with obesity and type 2 diabetes who have trouble losing weight and keeping their blood sugar levels in check. Tirzepatide may not be accepted or suited for all patients, and more study is needed to confirm its safety and effectiveness.
How does Tirzepatide work?
Targeting and activating GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide) receptors is how Tirzepatide achieves its medicinal value. These receptors are essential for controlling hunger and blood sugar levels.
In reaction to eating, the body produces the hormones GLP-1 and GIP. They signal the brain to reduce hunger and promote feelings of fullness, which together aid in lowering blood sugar levels.
It is an agonist, activating the GLP-1 and GIP receptors more than the body’s natural hormones. Tirzepatide’s ability to stimulate insulin secretion, lower blood sugar levels, and improve satiety to aid in weight loss is well established.
Tirzepatide’s potential metabolic benefits extend beyond its effects on GLP-1 and GIP receptors. It may include, for example, reduced inflammation and improved lipid profiles.
Tirzepatide is currently in the research phase, so more work is needed to determine how it works. What hazards and benefits it may have.
What is the function of the Tirzepatide pen?
The Tirzepatide pen has an embedded needle that administers the medication. When you inject yourself with the Tirzepatide pen, the needle goes in when you press the button and comes out when you release pressure.
The Tirzepatide pen is to be used once weekly, on a day that is convenient for you. The medicine can be injected into the upper arm, thigh, or abdomen.
It is most effective when stored at a cool (36°F to 46°F) temperature. The single-use pen must be disposed of in a sharps container approved by the FDA.
How often should Tirzepatide be taken?
All patients should start taking Tirzepatide at a lower dose of 2.5 mg to test how well it is tolerated. If your doctor tells you to do anything, you should do it. The recommended dosage plan for Tirzepatide is as follows:
- 1st Month: 2.5 mg/week
- 2nd Month: 5 mg once each week
- 3rd month: 7.5 mg once each week
- 4th month: 10mg once each week
- 5th Month: 12.5 mg once every week
- 6th Month: 15mg once a week (maximum dose)
What are the Tirzepatide side effects?
Tirzepatide is an investigational medication that is still undergoing clinical trials. But, early studies have shown that it may cause side effects in some patients. In clinical trials, the following are the most frequently reported adverse effects:
- Nausea
- Diarrhea
- Vomiting
- Decreased appetite
- Constipation
- Side effects from injections such as pain, redness, or swelling
Less common side effects of Tirzepatide may include:
- Hypoglycemia (low blood sugar)
- Gallbladder disease or gallstones
- Kidney problems, including acute kidney injury or worsening of chronic kidney disease
- Pancreatitis (inflammation of the pancreas)
- Thyroid cancer
It is important to note that the safety and efficacy of Tirzepatide are still being evaluated. More side effects may be identified as clinical trials continue. Patients considering Tirzepatide should discuss the potential benefits and risks with their healthcare provider.
Does the Food and Drug Administration approve Tirzepatide for weight loss?
As far as I know, the FDA has yet to approve Tirzepatide for weight loss as of September 2021. Phase 3 clinical trials are now investigating its efficacy in helping persons with obesity and type 2 diabetes lose weight and better regulate their blood sugar levels.
Tirzepatide, sold under the brand Zegalogue, has been approved by the FDA for treating type 2 diabetes. Adults with diabetes can use this drug to treat life-threatening hypoglycemia (low blood sugar).
Tirzepatide may not be an appropriate or safe option for all patients, and its safety and efficacy for weight loss are still being studied.
Tirzepatide or Semaglutide: Which Is More Effective?
Who Should Not Use Tirzepatide?
Both the safety and effectiveness of tirzepatide are currently being determined through ongoing clinical research. Therefore, Tirzepatide use should be approached with caution or avoided altogether in a small subset of the population. For example:
Those with a family history of medullary thyroid cancer (MTC) or MENAS Type 2 (MEN 2). Those with a history of MTC or MEN 2 should avoid taking tirzepatide because of the drug’s link to an increased risk of thyroid cancers in animal studies.
Those who have previously suffered from pancreatitis. Pancreatitis is an inflammation of the pancreas that can be exacerbated by tirzepatide. Tirzepatide shouldn’t be taken by those who have had pancreatitis.
Those who suffer from severe cases of digestive difficulties or motility issues. The gastrointestinal side effects of tirzepatide include nausea, vomiting, and diarrhea. These adverse effects may more likely occur in people with a severe gastrointestinal illness or motility difficulties.
Those who have serious kidney damage. Those with severe renal impairment may be at a higher risk for side effects from tirzepatide because the drug is flushed out of the body via the kidneys.
When deciding whether or not Tirzepatide is appropriate for a patient, these are not the only considerations healthcare providers will consider. Tirzepatide use should only be decided upon after discussing the pros and downs with a medical professional.
Conclusion
Many of you are interested in finding weight reduction therapies but need to know where to start exploring. Alma MedSpa in St. Charles, Missouri, is the only place to look. We’re here to answer all your questions about our weight loss services and procedures. If you have any questions or concerns about the course of treatment, our highly trained medical staff is here to help.
There are many options for losing weight, so you might need clarification about which to pick. Our experts are here to take care of that for you, taking into account your age, weight, and any other health concerns you may have. You’ll benefit from their extensive knowledge of the human body and how to choose the most effective weight reduction solution.
If you’re looking for the greatest weight reduction therapy in Missouri, go no further than Alma MedSpa in St. Charles. The first step in your weight loss journey with Alma MedSpa is as close as a phone call.
